ARCHIVES

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

This article is from The Cancer Letter archive.

Vol. 04 No. 03 | January 20, 1978

Download PDF Visit The Full Archive

Related Articles

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Prime Contract Subcontract Opportunities

January 24, 1975